Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-04-15A Prospective Study of Long-Term Clinical, Virologic, and Immunologic Outcomes in HIV-Infected Individuals
-
CLINICAL_TRIALS study record update · 2014-04-14A Randomised Controlled Trial Comparing the Efficacy of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir (LPV/r) Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
-
CLINICAL_TRIALS study record update · 2014-04-11An Open-label Study of Liquid and Sprinkled Formulations of Efavirenz Administered in Combination With Didanosine and Emtricitabine in HIV-infected Infants and Children 3 Months to 6 Years of Age.
-
CLINICAL_TRIALS study record update · 2014-04-11Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya: a Randomized Trial
-
CLINICAL_TRIALS study record update · 2014-04-11Early Access of TMC114 in Combination With Low-dose Ritonavir (TMC/r)) and Other Antiretrovirals (ARVs) in Highly Treatment Experienced HIV-1 Infected Patients With Limited to no Treatment Options.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-04-09Prospective Study of the Determinants of Host Resistance to HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2014-04-08Project UNITY - A Randomized Trial of Enhanced HIV Risk Reduction and Vaccine Education Interventions in Reducing Sexual Risk and Increasing Vaccine Trial Knowledge Among HIV-negative, High-risk Women Who Use Non-injection Drugs
-
CLINICAL_TRIALS study record update · 2014-04-02A Phase I, Open-label, Single-sequence Drug-drug Interaction Trial to Investigate the Pharmacokinetic Interaction Between Steady-state Nevirapine and Single-dose TMC207 in HIV-1 Infected Subjects.
-
CLINICAL_TRIALS study record update · 2014-03-24Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
-
CLINICAL_TRIALS study record update · 2014-03-24Comparison of Liquid Kaletra and Low Dose Kaletra Tablets in HIV-Positive Children
-
CLINICAL_TRIALS study record update · 2014-03-20Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy
-
CLINICAL_TRIALS study record update · 2014-03-20Study of the Influence of Atorvastatin in Plasma Viral Replication Given Prior to Antiretroviral Treatment Interruption in Patients With HIV-1 Infection and Viral Suppression.
-
CLINICAL_TRIALS study record update · 2014-03-18Cardiac Status of HAART Exposed Infants of HIV-Infected Mothers (CHAART I)
-
CLINICAL_TRIALS study record update · 2014-03-18HAART Associated Cardiotoxicity in HIV-Infected Children
-
CLINICAL_TRIALS study record update · 2014-03-17A Preliminary Evaluation of Fanconi Syndrome Due to Antiretroviral Therapies in HIV-Infected Persons
-
CLINICAL_TRIALS study record update · 2014-03-12Open-label Multicenter Study to Assess the Efficacy, the Tolerability and the Adherence of a Once Daily (QD) Taken Antiretroviral Therapy (ART) Containing the NtRTI Tenofovir DF 300 mg in Combination With the Best Suitable Once a Day Regimen Being 1 NRTI Plus 1 PI or 1 NRTI Plus 1 NNRTI in HIV-1-infected IVDU- Patients With Opiate Substitution Being Either Antiretroviral-naive or With Suppressed Viral Load and Without a History of Virological Failure
-
CLINICAL_TRIALS study record update · 2014-03-10A Study of Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C or Hepatitis B
-
CLINICAL_TRIALS study record update · 2014-03-10Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder, Adherence to Antiretroviral Therapy,Cognition, and Immune Status Among Patients With HIV and AIDS: A 6-week Open-label, Prospective, Pilot Trial.
-
CLINICAL_TRIALS study record update · 2014-03-07Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
-
CLINICAL_TRIALS study record update · 2014-02-28An Open-Label, Pilot Study to Characterize the Pharmacokinetics of a 400mg Oral Dose of Raltegravir in the Cervicovaginal Fluids of HIV-Infected Pre-menopausal Women
-
CLINICAL_TRIALS study record update · 2014-02-26Phase II Study of Autologous Myeloid Dendritic Cells as a "Cellular Adjuvant" for a Therapeutic HIV-1 Vaccine in Early Stage HIV-1+ Patients (DCV-2).
-
CLINICAL_TRIALS study record update · 2014-02-19A Phase III Randomized, Double-blind Study to Demonstrate the Antiviral Activity of Dolutegravir (DTG) 50 mg Twice Daily Versus Placebo Both Co-Administered With a Failing Antiretroviral Regimen Over Seven Days, Followed by an Open Label Phase With All Subjects Receiving DTG 50 mg Twice Daily Co-administered With an Optimised Background Regimen (OBR) in HIV-1 Infected, Integrase Inhibitor Therapy-Experienced and Resistant, Adults
-
CLINICAL_TRIALS study record update · 2014-02-14Collection of Data on the Management of HIV-1 Patients Treated With Antiretroviral Combination Therapy Including the HIV Integrase Inhibitor Raltegravir
-
CLINICAL_TRIALS study record update · 2014-02-13Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
-
CLINICAL_TRIALS study record update · 2014-02-13Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Human Growth Hormone and/or Rosiglitazone in the Treatment of Human Immunodeficiency Virus-Associated Visceral Adiposity and Insulin Resistance